Moderate Caffeine Intake Linked to Lower Dementia Risk

A long-term study of nearly 132,000 people finds moderate caffeinated coffee or tea intake linked to an 18% lower dementia risk. Results are associative, not causal, and benefits plateau beyond moderate consumption.

Nora Schmidt Nora Schmidt . 2 Comments
Moderate Caffeine Intake Linked to Lower Dementia Risk

5 Minutes

Think of your morning cup as a tiny, repeatable experiment. New long-term data now suggest that moderate consumption of caffeinated beverages—coffee or tea—may be associated with a modest reduction in the risk of developing dementia decades later.

The finding comes from an analysis of nearly 132,000 men and women tracked for up to 43 years. Researchers pooled data from two major U.S. cohorts—the Nurses' Health Study and the Health Professionals Follow-up Study—then compared reported caffeine intake with later diagnoses of dementia and with participants' self-reported cognitive changes. The headline result: people in the highest caffeine group had a lower incidence of dementia than those who drank little or no caffeine.

Participants with the largest reported caffeine intakes experienced an 18 percent lower risk of developing dementia compared with the lowest-intake group. That risk reduction persisted after adjusting for multiple lifestyle and medical factors, suggesting a consistent association across different backgrounds and health profiles.

A chart illustrating the hazard ratio for dementia with caffeinated coffee intake, in cups per day

What the study measured and what it didn't

Researchers calculated caffeine intake from food-frequency questionnaires administered every two to four years, which asked about coffee, tea, soda and other sources. Cognitive outcomes came from two types of data: nearly 17,000 participants completed telephone-based cognitive testing several times during follow-up, and a broader group reported perceived changes in memory or attention. Over the whole sample of 131,821 people, 11,033 developed dementia.

Not every result pointed in the same direction. Those who drank caffeinated coffee or tea reported slightly better cognitive scores on subjective measures, but the composite objective test scores in the tested subgroup did not show a statistically significant difference between highest and lowest caffeine consumers. Additionally, the protective signal was not present for decaffeinated beverages, suggesting that caffeine itself may be the active factor rather than other compounds in coffee or tea.

Observational studies like this one can point to meaningful associations. They cannot, however, by themselves prove cause and effect. Confounding variables—dietary patterns, exercise, sleep, socioeconomic factors—can never be fully eliminated, though the authors controlled for many of them. Studies using randomized designs or mechanistic lab work are still needed to test whether caffeine directly alters brain aging processes.

Context: how this fits with other research

These results echo and extend a set of earlier findings. Analyses of the UK Biobank and other cohorts have linked caffeinated coffee with lower incidence of Alzheimer’s and Parkinson’s in some samples, while separate studies have associated three cups of coffee a day with a small increase in life expectancy. Some research has also pointed to tea as beneficial, particularly among people with specific cardiovascular risk profiles.

Not every comparison is consistent. A few studies report higher dementia risk at very high consumption levels—six or more cups a day—suggesting a U-shaped relationship in some populations. In the new analysis, however, benefits plateaued rather than reversed: higher intake beyond the moderate range did not appear harmful, but it also did not confer additional gains.

Why might caffeine help? Small laboratory studies and animal models hint at several plausible mechanisms: caffeine can reduce neuroinflammation, modulate adenosine receptors involved in neuronal signaling, and affect amyloid and tau pathways linked to Alzheimer’s pathology. But translating these molecular signals into population-level protection requires careful work across disciplines.

Expert Insight

“The effect size is modest, but still notable at the population level,” says Dr. Maya Collins, a cognitive epidemiologist at the Center for Brain Health (fictional). “If even a small percentage of people shift from no caffeine to moderate regular intake, the public-health implications could be meaningful. Importantly, caffeine should be considered one of many lifestyle factors—exercise, sleep, blood pressure control and social engagement remain primary levers in dementia prevention.”

Practical takeaways? Moderate intake—roughly two to three cups of brewed coffee or one to two cups of tea per day—was where the most consistent associations appeared. Decaffeinated options did not show the same link, reinforcing the hypothesis that caffeine is the active element. And while caffeine is generally safe for many adults, tolerance, sleep interference, cardiovascular concerns and medication interactions mean personalized advice remains essential.

This study adds to a nuanced picture: caffeine is unlikely to be a miracle shield against dementia, but it may be a small, manageable piece of a broader strategy to preserve cognitive health into late life.

Source: sciencealert

“The cosmos has always fascinated me. I write about space missions, astronomy, and the technologies pushing humanity beyond Earth.”

Leave a Comment

Comments

coinpilot

Is this even true? observational study, many confounders. also how much is 'cup' standardised? different ppl, different strengths...

bioNix

wow didnt expect caffeine to show up decades later. modest effect, but if thats real then...